Lorence Kim, M.D.
Lorence Kim joined TRV as a venture partner in 2020. He was previously the Chief Financial Officer of Moderna, guiding $4.4 billion of capital raising to support the company’s platform efforts in mRNA medicines and the discovery and development of a pipeline of 20+ candidates across infectious disease, oncology, rare disease and autoimmune disease. Prior to Moderna, Lorence spent 14 years at Goldman Sachs, where his last role was the co-head of the US biotech banking practice. Lorence is a member of the Board of Governors of the American Red Cross, and previously served on the board of directors of Seres Therapeutics. Lorence lives with his wife and three children in New York City.
- A.B., Biochemical Sciences, Harvard University
- M.D., University of Pennsylvania School of Medicine
- MBA, Healthcare Management, The Wharton School of the University of Pennsylvania
- East Coast